1. 1. European Agency for the Evaluation of Medical Products. Public Statement: EU-US FDA Bilateral Agreement (EMEA, London, UK, 2003
2. 2. accessed 8 September 2009). http://www.emea.europa.eu/pdfs/general/direct/pr/2447803en.pdf
3. 3. The Food and Drug Administration. Guidance for Industry: Pharmacogenomic Data Submissions (FDA, Rockville, Maryland, USA, March 2005
4. 4. accessed 8 September 2009). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm079849.pdf
5. European Agency for the Evaluation of Medical Products. Medicines and Emerging Science (EMEA, London, UK, accessed 8 September 2009)
http://www.emea.europa.eu/htms/human/mes/emergingtechnologies.htm